Social Security Ruling, SSR 99-2p.; Titles II and XVI: Evaluating
Cases Involving Chronic Fatigue Syndrome (CFS)
AGENCY: Social Security Administration.
ACTION: Notice of Social Security Ruling.
SUMMARY: In accordance with 20 CFR 402.35(b)(1), the Commissioner of
Social Security gives notice of Social Security Ruling, SSR 99-2p. This
Ruling clarifies disability policy for the evaluation and adjudication
of disability claims invo1ving Chronic Fatigue Syndrome (CFS). This
Ruling explains that, when it is accompanied by appropriate medical
signs or laboratory findings, CFS is a medically determinable
impairment that can be the basis for a finding of ``disability.'' This
Ruling ensures that all adjudicators will use the same policies and
procedures in evaluating disability claims involving CFS, and provides
a consolidated statement of these policies and procedures.
EFFECTIVE DATE: April 30, 1999.
FOR FURTHER INFORMATION CONTACT:
Carolyn Kiefer
Office of Disability
Division of Medical and Vocational Policy
Social Security Administration
6401 Security Boulevard
Baltimore, MD 21235-6401
(410) 965-9104.
SUPPLEMENTARY INFORMATION: Although we are not required to do so
pursuant to 5 U.S.C. 552(a)(1) and (a)(2), we are publishing this
Social Security Ruling in accordance with 20 CFR 402.35(b)(1).
Social Security Rulings make available to the public precedential
decisions relating to the Federal old-age, survivors, disability,
supplemental security income, and black lung benefits programs. Social
Security Rulings may be based on case decisions made at all
administrative levels of adjudication, Federal court decisions,
Commissioner's decisions, opinions of the Office of the General
Counsel, and policy interpretations of the law and regulations.
Although Social Security Rulings do not have the same force and
effect as the statute or regulations, they are binding on all
components of the Social Security Administration, in accordance with 20
CFR 402.35(b)(1), and are to be relied upon as precedents in
adjudicating cases.
If this Social Security Ruling is later superseded, modified, or
rescinded, we will publish a notice in the Federal Register to that
effect.
(Catalog of Federal Domestic Assistance, Programs 96.001 Social
Security--Disability Insurance; 96.006 Supplemental Security Income)
Dated: April 23, 1999.
Kenneth S. Apfel,
Commissioner of Social Security.
Policy Interpretation Ruling Titles II and XVI: Evaluating Cases
Involving Chronic Fatigue Syndrome (CFS)
Purpose
To restate and clarify the policies of the Social Security
Administration for developing and evaluating title II and title XVI
claims for disability on the basis of Chronic Fatigue Syndrome (CFS),
also frequently known as Chronic Fatigue and Immune Dysfunction
Syndrome.
Citations (Authority)
Sections 216(i), 223(d), 223(f), 1614(a)(3) and 1614(a)(4) of the
Social Security Act, as amended; Regulations No. 4, subpart P, sections
404.1505, 40404.1508-404.1513, 404.1520, 404.1520a, 404.1521, 404.1523,
404.1526-404.1529, 404.1560-404.1569a and 404.1593-404.1594;
[[Page 23381]]
and Regulations No. 16, subpart I, sections 416.905, 416.906, 416.908-
416.913, 416.920, 416.920a, 416.921, 416.923, 416.924, 416.924b,
416.924c, 416.926, 416.926a, 416.927-416.929, 416.960-416.969a,
416.987, 416.993, 416.994, and 416.994a.
Introduction
CFS is a systemic disorder consisting of a complex of symptoms that
may vary in incidence, duration, and severity. The current case
criteria for CFS, developed by an international group convened by the
Centers for Disease Control and Prevention (CDC) as an identification
tool and research definition, include a requirement for four or more of
a specified list of symptoms. These constitute a patient's complaints
as reported to a provider of treatment.
However, the Social Security Act (the Act) and our implementing
regulations require that an individual establish disability based on
the existence of a medically determinable impairment; i.e., one that
can be shown by medical evidence, consisting of medical signs, symptoms
and laboratory findings. Disability may not be established on the basis
of an individual's statement of symptoms alone.
This Ruling explains that CFS, when accompanied by appropriate
medical signs or laboratory findings, is a medically determinable
impairment that can be the basis for a finding of ``disability.'' It
also provides guidance for the evaluation of claims involving CFS.
Policy Interpretation
CFS constitutes a medically determinable impairment when it is
accompanied by medical signs or laboratory findings, as discussed
below. CFS may be a disabling impairment.
Definition of CFS
CFS is a systemic disorder consisting of a complex of symptoms that
may vary in incidence, duration, and severity. It is characterized in
part by prolonged fatigue that lasts 6 months or more and that results
in substantial reduction in previous levels of occupational,
educational, social, or personal activities. In accordance with
criteria established by the CDC, a physician should make a diagnosis of
CFS ``only after alternative medical and psychiatric causes of chronic
fatiguing illness have been excluded'' (Annals of Internal Medicine,
121:953-9, 1994). CFS has been diagnosed in children, particularly
adolescents, as well as in adults.
Under the CDC definition, the hallmark of CFS is the presence of
clinically evaluated, persistent or relapsing chronic fatigue that is
of new or definite onset (i.e., has not been lifelong), cannot be
explained by another physical or mental disorder, is not the result of
ongoing exertion, is not substantially alleviated by rest, and results
in substantial reduction in previous levels of occupational,
educational, social, or personal activities. Additionally, the current
CDC definition of CFS requires the concurrence of 4 or more of the
following symptoms, all of which must have persisted or recurred during
6 or more consecutive months of illness and must not have pre-dated the
fatigue:
Self-reported impairment in short-term memory or
concentration severe enough to cause substantial reduction in
previous levels of occupational, educational, social, or personal
activities;
Sore throat;
Tender cervical or axillary lymph nodes;
Muscle pain;
Multi-joint pain without joint swelling or redness;
Headaches of a new type, pattern, or severity;
Unrefreshing sleep; and
Postexertional malaise lasting more than 24 hours.
Within these parameters, an individual with CFS can also exhibit a
wide range of other manifestations, such as muscle weakness, swollen
underarm (axillary) glands, sleep disturbances, visual difficulties
(trouble focusing or severe photosensitivity), orthostatic intolerance
(e.g., lightheadedness or increased fatigue with prolonged standing),
other neurocognitive problems (e.g., difficulty comprehending and
processing information), fainting, dizziness, and mental problems
(e.g., depression, irritability, anxiety).
Requirement for a Medically Determinable Impairment
Sections 216(i) and 1614(a)(3) of the Act define ``disability''
1 as the inability to engage in any substantial gainful
activity (SGA) by reason of any medically determinable physical or
mental impairment (or combination of impairments) which can be expected
to result in death or which has lasted or can be expected to last for a
continuous period of not less than 12 months.2 Sections
223(d)(3) and 1614(a)(3)(D) of the Act, and 20 CFR 404.1508 and 416.908
require that an impairment result from anatomical, physiological, or
psychological abnormalities that can be shown by medically acceptable
clinical and laboratory diagnostic techniques. The Act and regulations
further require that an impairment be established by medical evidence
that consists of signs, symptoms, and laboratory findings, and not only
by an individual's statement of symptoms.
\1\ Except for statutory blindness.
\2\ For individuals under age 18 claiming benefits under title
XVI, disability will be established if the individual is suffering
from a medically determinable physical or mental impairment (or
combination of impairments) that results in ``marked and severe
functional limitations.'' See section 1614(a)(3)(C) of the Act and
20 CFR 416.906. However, for clarity, the following discussions
refer only to claims of individuals claiming disability benefits
under title II and individuals age 18 or older claiming disability
benefits under title XVI. The concepts in this ruling, however, are
also intended to apply in determining disability based on CFS for
individuals under age 18 under title XVI.
Under the CDC definition, the diagnosis of CFS can be made based on
an individual's reported symptoms alone once other possible causes for
the symptoms have been ruled out. However, the foregoing statutory and
regulatory provisions require that, for evaluation of claims of
disability under the Act, there must also be medical signs or
laboratory findings before the existence of a medically determinable
impairment may be established.
Establishing the Existence of a Medically Determinable Impairment
The following medical signs and laboratory findings establish the
existence of a medically determinable impairment in individuals who
have CFS. Although no specific etiology or pathology has yet been
established for CFS, many research initiatives continue, and some
progress has been made in ameliorating symptoms in selected
individuals. With continuing scientific research, new medical evidence
may emerge that will further clarify the nature of CFS and provide
greater specificity regarding the clinical and laboratory diagnostic
techniques that should be used to document this disorder.
Because of this, the medical criteria discussed below are only
examples of signs and laboratory findings that will establish the
existence of a medically determinable impairment; they are not all-
inclusive. As progress is made in medical research into CFS, additional
signs and laboratory findings may also be found that can be used to
establish that individuals with CFS have a medically determinable
impairment. The existence of CFS may be documented with medical signs
or laboratory findings other than those listed below, provided that
such documentation is consistent with medically accepted clinical
practice and is consistent with the other evidence in the case record.
[[Page 23382]]
Examples of Medical Signs That Establish the Existence of a Medically
Determinable Impairment
For purposes of Social Security disability evaluation, one or more
of the following medical signs clinically documented over a period of
at least 6 consecutive months establishes the existence of a medically
determinable impairment for individuals with CFS:
Palpably swollen or tender lymph nodes on physical
examination;
Nonexudative pharyngitis;
Persistent, reproducible muscle tenderness on repeated
examinations, including the presence of positive tender points;
3 or,
\3\ There is considerable overlap of symptoms between CFS and
Fibromyalgia Syndrome (FMS), but individuals with CFS who have
tender points have a medically determinable impairment. Individuals
with impairments that fulfill the American College of Rheumatology
criteria for FMS (which includes a minimum number of tender points)
may also fulfill the criteria for CFS. However, individuals with CFS
who do not have the specified number of tender points to establish
FMS, will still be found to have a medically determinable
impairment.
Any other medical signs that are consistent with
medically accepted clinical practice and are consistent with the
other evidence in the case record.
Examples of Laboratory Findings That Establish the Existence of a
Medically Determinable Impairment
At this time, there are no specific laboratory findings that are
widely accepted as being associated with CFS. However, the absence of a
definitive test does not preclude reliance upon certain laboratory
findings to establish the existence of a medically determinable
impairment in persons with CFS. Therefore, the following laboratory
findings establish the existence of a medically determinable impairment
in individuals with CFS: 4
\4\ It should be noted that standard laboratory test results in
the ``normal'' range are characteristic for many individuals with
CFS, and should not be relied upon to the exclusion of all other
clinical evidence in decisions regarding the presence and severity
of a medically determinable impairment.
An elevated antibody titer to Epstein-Barr virus (EBV)
capsid antigen equal to or greater than 1:5120, or early antigen
equal to or greater than 1:640;
An abnormal magnetic resonance imaging (MRI) brain
scan;
Neurally mediated hypotension as shown by tilt table
testing or another clinically accepted form of testing; or,
Any other laboratory findings that are consistent with
medically accepted clinical practice and are consistent with the
other evidence in the case record; for example, an abnormal exercise
stress test or abnormal sleep studies, appropriately evaluated and
consistent with the other evidence in the case record.
Mental Findings That Establish the Existence of a Medically
Determinable Impairment
Some individuals with CFS report ongoing problems with short-term
memory, information processing, visual-spatial difficulties,
comprehension, concentration, speech, word-finding, calculation, and
other symptoms suggesting persistent neurocognitive impairment. When
ongoing deficits in these areas have been documented by mental status
examination or psychological testing, such findings constitute medical
signs or (in the case of psychological testing) laboratory findings
that establish the presence of a medically determinable impairment.
Individuals with CFS may also exhibit medical signs, such as
anxiety or depression, indicative of the existence of a mental
disorder. When such medical signs are present and appropriately
documented, the existence of a medically determinable impairment is
established.
Evaluation
General. Claims involving CFS are adjudicated using the
sequential evaluation process, just as for any other impairment. Once a
medically determinable impairment has been found to exist (see
discussion above), the severity of the impairment(s) must be
established. The severity of an individual's impairment(s) is
determined based on the totality of medical signs, symptoms, and
laboratory findings, and the effects of the impairment(s), including
any related symptoms, on the individual's ability to function.
Also, several other
disorders (including, but not limited to, FMS,
multiple chemical sensitivity, and Gulf War Syndrome, as well as
various forms of depression, and some neurological and psychological
disorders) may share characteristics similar to those of CFS. When
there is evidence of the potential presence of another disorder that
may adequately explain the individual's symptoms, it may be necessary
to pursue additional medical or other development.
Step 2. When an adjudicator finds that an individual with CFS
has a medically determinable impairment, he or she must consider that
the individual has an impairment that could reasonably be expected to
produce the individual's symptoms associated with CFS, as required in
20 CFR 404.1529(b) and 416.929(b), and proceed to evaluate the
intensity and persistence of the symptoms. Thus, if an adjudicator
concludes that an individual has a medically determinable impairment,
and the individual alleges fatigue, pain, symptoms of neurocognitive
problems, or other symptoms consistent with CFS, these symptoms must be
considered in deciding whether the individual's impairment is
``severe'' at step 2 of the sequential evaluation process and at any
later steps reached in the sequential evaluation process. If fatigue,
pain, neurocognitive symptoms, or other symptoms are found to cause a
limitation or restriction having more than a minimal effect on an
individual's ability to perform basic work activities, the adjudicator
must find that the individual has a ``severe'' impairment. See SSR 96-
3p, ``Titles II and XVI: Considering Allegations of Pain and Other
Symptoms in Determining Whether a Medically Determinable Impairment is
Severe.''
Step 3. When an individual is found to have a severe impairment,
the adjudicator must proceed with the sequential evaluation process and
must next consider whether the individual's impairment is of the
severity contemplated by the Listing of Impairments contained in
appendix 1, subpart P of 20 CFR 404. Inasmuch as CFS is not a listed
impairment, an individual with CFS alone cannot be found to have an
impairment that meets the requirements of a listed impairment; however,
the specific findings in each case should be compared to any pertinent
listing to determine whether medical equivalence may exist.5
\5\ In evaluating title XVI claims for disability benefits for
individuals under age 18, consideration must also be given to the
possibility of functional equivalence. See 20 CFR 416.926a.
Further, in cases in which individuals with CFS have psychological
manifestations related to CFS, consideration should always be given to
whether the individual's impairment meets or equals the severity of any
impairment in the mental disorders listings in 20 CFR, part 404,
subpart P, appendix 1, sections 12.00 ff. or 112.00 ff.
Steps 4 and 5. For those impairments that do not meet or equal
the severity of a listing, an assessment of residual functional
capacity (RFC) must be made, and adjudication must proceed to the
fourth and, if necessary, the fifth step of the sequential evaluation
process.6 In assessing RFC, all of the individual's symptoms
must be considered in deciding how such symptoms may affect functional
capacities. See SSR 96-7p, ``Titles II and
[[Page 23383]]
XVI: Evaluation of Symptoms in Disability Claims: Assessing the
Credibility of an Individual's Statements'' and SSR 96-8p, ``Titles II
and XVI: Assessing Residual Functional Capacity in Initial Claims.''
\6\ These steps of the sequential evaluation process are not
applicable to claims for benefits under title XVI for individuals
under age 18. See 20 CFR 416.924.
If it is determined that the individual's impairment(s) precludes
the performance of past relevant work (or if there was no past relevant
work), a finding must be made about the individual's ability to perform
other work. The usual vocational considerations (see 20 CFR 404.1560-
404.1569a and 416.960-416.969a) must be applied in determining the
individual's ability to perform other work.
Many individuals with CFS are ``younger individuals,'' ages 18
through 49 (see 20 CFR 404.1563 and 416.963). Age, education, and work
experience are not usually considered to limit significantly the
ability of individuals under age 50 to make an adjustment to other
work, including unskilled sedentary work.7 However, a
finding of ``disabled'' is not precluded for those individuals under
age 50 who do not meet all of the criteria of a specific rule and who
do not have the ability to perform a full range of sedentary work. The
conclusion about whether such individuals are disabled will depend
primarily on the nature and extent of their functional limitations or
restrictions. Thus, if it is found that an individual is able to do
less than the full range of sedentary work, refer to SSR 96-9p,
``Titles II and XVI: Determining Capability to Do Other Work--
Implications of a Residual Functional Capacity for Less Than a Full
Range of Sedentary Work.'' As explained in that Ruling, whether the
individual will be able to make an adjustment to other work requires
adjudicative judgment regarding factors such as the type and extent of
the individual's limitations or restrictions and the extent of the
erosion of the occupational base for sedentary work.
\7\ However, ``younger individuals'' ages 45-49 who are
illiterate in English or unable to communicate in English, whose
past work was unskilled (or who had no past relevant work), or who
have no transferable skills, and who are limited to a full range of
sedentary work, must be found disabled under rule 201.17 in Table
No. 1 of appendix 2 of the Medical-Vocational Guidelines in 20 CFR
part 404.
Duration. The medical signs and symptoms of CFS fluctuate in
frequency and severity and often continue over a period of many months
or years. Thus, appropriate documentation should include a longitudinal
clinical record of at least 12 months prior to the date of application,
unless the alleged onset of CFS occurred less than 12 months in the
past, or unless a fully favorable determination or decision can be made
without additional documentation. The record should contain detailed
medical observations, treatment, the individual's response to
treatment, and a detailed description of how the impairment limits the
individual's ability to function over time.
When the alleged onset of disability secondary to CFS occurred less
than 12 months before adjudication, the adjudicator must evaluate the
medical evidence and project the degree of impairment severity that is
likely to exist at the end of 12 months.8 Information about
treatment and response to treatment as well as any medical source
opinions about the individual's prognosis at the end of 12 months are
helpful in deciding whether the medically determinable impairment(s) is
expected to be of disabling severity for at least 12 consecutive
months.
\8\ To meet the statutory requirement for ``disability,'' an
individual must have been unable to engage in any SGA by reason of
any medically determinable physical or mental impairment which is
expected to result in death or which has lasted or can be expected
to last for a continuous period of not less than 12 months. Thus,
the existence of an impairment for 12 continuous months is not
controlling; rather, it is the existence of a disabling impairment
which has lasted or can be expected to last for at least 12 months
that meets the duration requirement of the Act.
Continuing Disability Reviews. In those cases in which an
individual is found to have a disability based on CFS but medical
improvement is anticipated, an appropriate continuing disability review
should be scheduled based on the probability of cessation under the
Medical Improvement Review Standard. This standard takes into account
relevant individual case facts such as the combined severity of other
chronic or static impairments and the individual's vocational factors.
Documentation
General.. As with all claims for disability under both title II
and title XVI, documentation of medical signs or laboratory findings in
cases involving CFS is critical to establishing the presence of a
medically determinable impairment. In cases in which CFS is alleged,
longitudinal clinical records reflecting ongoing medical evaluation and
treatment from the individual's medical sources, especially treating
sources, are extremely helpful in documenting the presence of any
medical signs or laboratory findings, as well as the individual's
functional status over time. Every reasonable effort should be made to
secure all available, relevant evidence in cases involving CFS to
ensure appropriate and thorough evaluation.
Generally, evidence for the 12-month period preceding the month of
application should be requested unless there is reason to believe that
development of an earlier period is necessary, or unless the alleged
onset of disability is less than 12 months before the date of the
application.
Recontacting Medical Sources/Consultative Examinations.
If the adjudicator finds that the evidence is inadequate to determine whether
the individual is disabled, he or she must first recontact the
individual's treating or other medical source(s) to determine whether
the additional information needed is readily available, in accordance
with 20 CFR 404.1512 and 416.912.9 Only after the
adjudicator determines that the information needed is not readily
available from the individual's health care provider(s), or that the
necessary information or clarification cannot be sought from the
individual's health care provider(s), should the adjudicator proceed to
arrange for a consultative examination(s) in accordance with 20 CFR
404.1519a and 416.919a. The type of consultative examination(s)
purchased will depend on the nature of the individual's symptoms and
the extent of the evidence already in the case record.
\9\ We may not seek additional evidence or clarification from a
medical source when we know from past experience that the source
either cannot or will not provide the necessary findings.
Resolution of Conflicts. It should be noted that conflicting
evidence in the medical record is not unusual in cases of CFS due to
the complicated diagnostic process involved in these cases.
Clarification of any such conflicts in the medical evidence should be
sought first from the individual's treating or other medical sources.
Medical opinions from treating sources about the nature and
severity of an individual's impairment(s) are entitled to deference and
may be entitled to controlling weight. If we find that a treating
source's medical opinion on the issue(s) of the nature and severity of
an individual's impairment(s) is well-supported by medically acceptable
clinical and laboratory diagnostic techniques and is not inconsistent
with the other substantial evidence in the case record, the adjudicator
will give it controlling weight. (See SSR 96-2p, ``Titles II and XVI:
Giving Controlling Weight to Treating Source Medical Opinions,'' and
SSR 96-5p, ``Titles II and XVI: Medical Source Opinions on
[[Page 23384]]
Issues Reserved to the Commissioner.'') 10
\10\ A medical source opinion that an individual is ``disabled''
or ``unable to work,'' has an impairment(s) that meets or is
equivalent in severity to the requirements of a listing, has a
particular residual functional capacity (RFC), that concerns whether
an individual's RFC prevents him or her from doing past relevant
work, or that concerns the application of vocational factors, is an
opinion on an issue reserved to the Commissioner. Every such opinion
must still be considered in adjudicating a disability claim;
however, the adjudicator will not give any special significance to
such an opinion because of its source. See SSR 96-5p, ``Titles II
and XVI: Medical Source Opinions on Issues Reserved to the
Commissioner.''
Assessing Credibility. In accordance with SSR 96-7p, if the
existence of a medically determinable impairment that could reasonably
be expected to produce the symptoms has been established, as outlined
above, but an individual's statements about the intensity, persistence,
or functionally limiting effects of symptoms are not substantiated by
objective medical evidence, the adjudicator must consider all of the
evidence in the case record, including any statements by the individual
and other persons concerning the individual's symptoms. The adjudicator
must then make a finding on the credibility of the individual's
statements about symptoms and their functional effects. When additional
information is needed to assess the credibility of the individual's
statements about symptoms and their effects, the adjudicator must make
every reasonable effort to obtain available information that could shed
light on the credibility of the individual's statements.
Treating and other medical sources. In evaluating credibility, the
adjudicator should ask the treating or other medical source(s) to
provide information about the extent and duration of an individual's
impairment(s), including observations and opinions about how well the
individual is able to function, the effects of any treatment, including
side effects, and how long the impairment(s) is expected to limit the
individual's ability to function. Opinions from an individual's medical
sources, especially treating sources, concerning the effects of CFS on
the individual's ability to function in a sustained manner in
performing work activities or in performing activities of daily living
are important in enabling adjudicators to draw conclusions about the
severity of the impairment(s) and the individual's RFC. In this regard,
any information a medical source is able to provide contrasting the
individual's impairment(s) and functional capacities since the alleged
onset of CFS with the individual's status prior to the onset of CFS
will be helpful in evaluating the individual's impairment(s) and its
functional consequences.
Third-party information, including evidence from medical sources
who are not ``acceptable medical sources'' for the purpose of
establishing the existence of a medically determinable impairment, but
who have provided services to the individual, may be very useful in
deciding the individual's credibility. Information other than an
individual's allegations and reports from the individual's treating
sources helps to assess an individual's ability to function on a day-
to-day basis and to depict the individual's capacities over a period of
time. Such evidence includes, but is not limited to:
Information from neighbors, friends, relatives, or clergy;
Statements from such individuals as past employers,
rehabilitation counselors, or school teachers about the individual's
impairment(s) and the effects of the impairment(s) on the
individual's functioning in the work place, rehabilitation facility,
or educational institution;
Statements from other practitioners with knowledge of
the individual, e.g., nurse-practitioners, physicians' assistants,
naturopaths, therapists, social workers, and chiropractors;
Statements from other sources with knowledge of the
individual's ability to function in daily activities; and
The individual's own record (such as a diary, journal,
or notes) of his or her own impairment(s) and its impact on function
over time.
The adjudicator should carefully consider this information when
making findings about the credibility of the individual's allegations
regarding functional limitations or restrictions.
EFFECTIVE DATE: This Ruling is effective on April 30, 1999.
CROSS-REFERENCES: SSR 96-2p, ``Titles II and XVI: Giving Controlling
Weight to Treating Source Medical Opinions,'' SSR 96-3p, ``Titles II
and XVI: Considering Allegations of Pain and Other Symptoms in
Determining Whether a Medically Determinable Impairment is Severe,''
SSR 96-4p, ``Titles II and XVI: Symptoms, Medically Determinable
Physical and Mental Impairments, and Exertional and Nonexertional
Limitations,'' SSR 96-5p, ``Titles II and XVI: Medical Source Opinions
on Issues Reserved to the Commissioner,'' SSR 96-7p, ``Titles II and
XVI: Evaluation of Symptoms in Disability Claims: Assessing the
Credibility of an Individual's Statements,'' SSR 96-8p, ``Titles II and
XVI: Assessing Residual Functional Capacity in Initial Claims,'' and
SSR 96-9p, ``Titles II and XVI: Determining Capability to Do Other
Work--Implications of a Residual Functional Capacity for Less Than a
Full Range of Sedentary Work.''